Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - RESEARCH & DEVELOPMENT
Research & Development IBRX - ImmunityBio, Inc.
232 M
LAST VALUE
8.89%
2 YEAR CAGR
34.18%
5 YEAR CAGR
86.93%
10 YEAR CAGR